SlideShare a Scribd company logo
1 of 26
Download to read offline
22nd Annual Health Sciences
Tax Conference
Medical device excise tax: ready or not?

December 5, 2012
Disclaimer


►    Any US tax advice contained herein was not intended or
     written to be used, and cannot be used, for the purpose of
     avoiding penalties that may be imposed under the Internal
     Revenue Code or applicable state or local tax law
     provisions.




Page 1               Medical device excise tax: ready or not?
Disclaimer

Ernst & Young refers to the global organization of member firms of Ernst & Young
Global Limited, each of which is a separate legal entity. Ernst & Young LLP is a client-
serving member firm of Ernst & Young Global Limited operating in the US. For more
information about our organization, please visit www.ey.com.

This presentation is © 2012 Ernst & Young LLP. All rights reserved. No part of this
document may be reproduced, transmitted or otherwise distributed in any form or by
any means, electronic or mechanical, including by photocopying, facsimile
transmission, recording, rekeying, or using any information storage and retrieval
system, without written permission from Ernst & Young LLP. Any reproduction,
transmission or distribution of this form or any of the material herein is prohibited and
is in violation of US and international law. Ernst & Young LLP expressly disclaims any
liability in connection with use of this presentation or its contents by any third party.

Views expressed in this presentation are not necessarily those of Ernst & Young LLP.




Page 2                      Medical device excise tax: ready or not?
Presenters

►   Mar Haeussler                              ►     Chris Ohmes
    Vice President                                   Ernst & Young LLP
    Economic Analysis/Transfer                       Washington, DC
    Pricing                                          +1 202 327 8753
    Olympus Center Valley, PA                        chris.ohmes@ey.com




Page 3                Medical device excise tax: ready or not?
Agenda

►   Introduction to MDET
►   Preparation for the medical device excise tax (MDET)
    ►    Supply chain mapping
    ►    Tax base
    ►    When liability arises
►   Amount of Liability
►   Compliance and IT considerations




Page 4                  Medical device excise tax: ready or not?
Introduction to the MDET
What is the MDET?

►   The MDET is a federal, ad valorem, manufacturers
    excise tax.
►   Enacted as part of the Patient Protection and Affordable
    Care Act, the MDET imposes on manufacturers,
    importers, and producers a tax at a rate of 2.3% of the
    price of the first sale or use of medical devices in the US.
►   The MDET is effective for taxable sales (and uses)
    occurring after December 31, 2012.
►   The MDET is incorporated into Chapter 32 of the Internal
    Revenue Code, thus a series of existing manufacturers
    excise tax rules apply to the MDET.


Page 6               Medical device excise tax: ready or not?
Preparation for the MDET
Where to start?

►   Do we obtain ownership of taxable medical devices in a
    way that potentially make us liable for the tax?
►   Do we make them?
►   Did we import them?
►   Are we treated as if we made them?
►   What about:
    ►    Kitting
    ►    Installation and/or periodic servicing
    ►    Repairs/refurbishing




Page 8                    Medical device excise tax: ready or not?
What are we talking about?

►   Taxable medical devices are defined with reference to
    Section 201(h) of the Federal Food, Drug and Cosmetic
    Act. A medical device is:
         ►   An instrument, apparatus, contrivance, in vitro reagent, recognized in
             the National Formulary or the US Pharmacopoeia
         ►   Intended for use in diagnosis of disease or other conditions or in the
             cure, mitigation, treatment or prevention of disease
         ►   Intended to affect the structure or any function of the body of man or
             other animals, in a non-chemical manner




Page 9                      Medical device excise tax: ready or not?
Who is liable for the tax?

►   MDET is imposed on the manufacturer, producer or
    importer of a taxable medical device.
►   For excise tax purposes, the term manufacturer includes a
    “producer” and an “importer.”
►   A manufacturer is a person who produces a taxable article
    by processing, manipulating or changing the form of an
    article or, by combining or assembling two or more
    articles.
►   The importer rule treats the importer as the manufacturer
    of imported goods.
►   MDET applies by legal entity, thus multiple entities within
    a controlled group can have compliance obligations.
Page 10             Medical device excise tax: ready or not?
Which devices are exempt?

►   Exemptions based on the product
    ►     Some medical devices are MDET-exempt because they are not
          listed with a three-letter Food and Drug Administration (FDA)
          product code.
    ►     Eyeglasses, hearing aids and contact lenses
    ►     Certain medical devices sold at retail, as specified in regulations
►   Exemptions based on sales
    ►     Exports (can we prove it?)
    ►     Sold for further manufacturing (shifting of liability)




Page 11                     Medical device excise tax: ready or not?
The retail exemption isn’t sales based?

►   Congress delegated to Treasury the authority to exempt
    medical devices, which are of a type generally purchased
    by the general public at retail for individual.
►   Internal Revenue Service (IRS) has proposed regulations
    indicating the retail exemption applies to medical devices
    ►     The device satisfies a three-part test:
          ►   It is regularly available for purchase and use by individual consumers
              who are not medical professionals.
          ►   The design demonstrates that it is not primarily intended for use in in a
              medical institution or office or by medical professionals.
    ►     Alternatively, the device satisfies one of the regulations’ safe
          harbor provisions



Page 12                      Medical device excise tax: ready or not?
Triggering liability for the tax

►   In general, the tax attaches to the first sale in the US after
    the completion of manufacturing of a taxable medical
    device
►   Importers are subject to the same first sale rule, when a
    taxable medical device is imported into the US.
►   Uses are also subject to the MDET
    ►     Leases
    ►     Rental arrangements not involving payments of rent
    ►     Loaners
    ►     Demonstration units




Page 13                   Medical device excise tax: ready or not?
Section 4191 medical device excise tax point
of attachment

          Do you manufacture,
           produce, or import     Yes               Do you export           Yes
           listed FDA medical                                                     No tax
                                                   medical devices?
            devices for use by
                humans?

                                                              No

               No
                                                      Do you sell
                                                  partially completed
                                                                            Yes   No tax
                                                   medical devices?

                No tax
                                                              No

                                                  Are they eyeglasses,
                                                     contact lenses,        Yes   No tax
                                                 hearing aids or exempt
                                                        devices?


                                                              Yes


                                  No                Do you sell, rent,
                                                   lease, lend or use       Yes
                                                                                  Tax due
                                                   medical devices?




Page 14                          Medical device excise tax: ready or not?
MDET liability
Identifying the tax price

►   The supply chain and distribution channels determine
    which prices can be used to calculate the tax.
►   Existing manufacturers’ excise tax rules assume a certain
    supply chain and distribution-channel paradigm – pricing
    rules follow from that paradigm.
►   Supply chain and distribution channels vary widely in the
    medical device industry.
►   Economic versus legal responsibility for MDET




Page 16             Medical device excise tax: ready or not?
The pricing paradigm

                  Seeking a manufacturer’s
                      wholesale price

     US
                     Unrelated                          Unrelated     End
manufacturer or
                     distributer                         retailer   customer
  Importer




Page 17            Medical device excise tax: ready or not?
What is a constructive sales price?

►   A fair market value price that the IRS may impose by
    statute
►   Applies only if tax is not paid on fair market value price.
►   IRS has issued numerous rulings allowing a fixed
    percentage of retail as a proxy for a wholesale price but
    these are specific to other excise taxes.
►   Most MDET taxpayers will want to avoid constructive
    pricing
►   Constructive price rules are set out in code Section
    4216(b)(1) through (b)(4)



Page 18              Medical device excise tax: ready or not?
At what price is the tax paid?
  Constructive price rules
Taxable Transaction is always the first sale or use
             Constructive Sales Price
             Taxable Sale
                                                                                 Unrelated
             Transfer Price                                                     wholesaler/
             True wholesale                                                     distributer               E
                                                                                                          n
                                                                                                          d
                                                                                 Related
                                        US
                                                                                wholesaler/
                                    manufacturer                                distributer               c
   Outside US                            or                                                               u
     (OUS)                            importer                                                Unrelated   s
   manufacturer                                                                                retailer   t
                                                                                                          o
                                                                                               Related    m
                                                                                               retailer
                                                                                                          e
                                                                                                          r



  Page 19                                      Medical device excise tax: ready or not?
Determining pricing

►   Price must reflect a return for all functions, intangibles and
    risks necessary to manufacture a finished device ready for
    the market
►   Existing regulations provide for the following exclusions
    ► Excise tax
    ► Transportation
    ► Delivery
    ► Insurance
    ► Installation charges




Page 20               Medical device excise tax: ready or not?
Pricing hot topics

►   Separately stating the tax on invoices
►   Intercompany sales to related distribution company
►   Rebates and sales incentives
►   Treatment of marketing intangibles and marketing costs
►   Services incorporated into sales price (training, repairs,
    loaners, etc.)
►   Application of Rev Rul 80-273
►   Vendor communications on tax-exempt sales
►   Razor and razor blade sales model



Page 21              Medical device excise tax: ready or not?
MDET compliance
Compliance issues

►   Tax deposits every two weeks, electronic federal tax
    payment system per legal entity
►   Quarterly form 720 (yet to be modified for MDET)
►   Form 637 exemption certificates
    ►     Acquire
    ►     Provide
    ►     Maintain
►   Record retention (and compliance with export and further
    manufacturing regulations)
►   Refunds



Page 23              Medical device excise tax: ready or not?
Compliance issues

►   No off the shelf software solution is available
►   Integration with Enterprise Resource Planning Software
    (ERP) or standalone?
►   Systems
    ►     Calculate tax and refunds
    ►     Create audit reports
    ►     Update financials
►   Customer relationship changes
►   Supplier relationship changes
►   Item master changes
►   Acquisitions

Page 24                   Medical device excise tax: ready or not?
Questions




Page 25     Medical device excise tax: ready or not?

More Related Content

Similar to The Medical Device Excise Tax: ready or not?

Treasury Issues Binding Guidance on Medical Device Excise Tax
Treasury Issues Binding Guidance on Medical Device Excise TaxTreasury Issues Binding Guidance on Medical Device Excise Tax
Treasury Issues Binding Guidance on Medical Device Excise Tax
Patton Boggs LLP
 
Dr13 the future_of_health_care_insurance_whats_ahead3
Dr13 the future_of_health_care_insurance_whats_ahead3Dr13 the future_of_health_care_insurance_whats_ahead3
Dr13 the future_of_health_care_insurance_whats_ahead3
Ariel Porath
 
consumer protection act.pptx
consumer protection act.pptxconsumer protection act.pptx
consumer protection act.pptx
ketan349068
 

Similar to The Medical Device Excise Tax: ready or not? (20)

Treasury Issues Binding Guidance on Medical Device Excise Tax
Treasury Issues Binding Guidance on Medical Device Excise TaxTreasury Issues Binding Guidance on Medical Device Excise Tax
Treasury Issues Binding Guidance on Medical Device Excise Tax
 
Oliver o'connor health insurance 24 march
Oliver o'connor health insurance 24 marchOliver o'connor health insurance 24 march
Oliver o'connor health insurance 24 march
 
Product liability insurance in china report by daxue consulting
Product liability insurance in china report by daxue consultingProduct liability insurance in china report by daxue consulting
Product liability insurance in china report by daxue consulting
 
BimaKing.com
BimaKing.comBimaKing.com
BimaKing.com
 
VIETNAM – INVESTMENT IN THE HEALTHCARE AND MEDICAL DEVICE SECTORS
VIETNAM – INVESTMENT IN THE HEALTHCARE AND MEDICAL DEVICE SECTORSVIETNAM – INVESTMENT IN THE HEALTHCARE AND MEDICAL DEVICE SECTORS
VIETNAM – INVESTMENT IN THE HEALTHCARE AND MEDICAL DEVICE SECTORS
 
German healthcare system.pptx
German healthcare system.pptxGerman healthcare system.pptx
German healthcare system.pptx
 
Icab lectures chapter last
Icab lectures chapter lastIcab lectures chapter last
Icab lectures chapter last
 
Devices Sponsor Information Day: 5 - Post-market - Advertising therapeutic go...
Devices Sponsor Information Day: 5 - Post-market - Advertising therapeutic go...Devices Sponsor Information Day: 5 - Post-market - Advertising therapeutic go...
Devices Sponsor Information Day: 5 - Post-market - Advertising therapeutic go...
 
Alert 31 14 - more bureaucracy hinders advertising in vietnam
Alert 31 14 - more bureaucracy hinders advertising in vietnamAlert 31 14 - more bureaucracy hinders advertising in vietnam
Alert 31 14 - more bureaucracy hinders advertising in vietnam
 
Presentation on marketing of medical devices in Europe (24.01.2012)
Presentation on marketing of medical devices in Europe (24.01.2012)Presentation on marketing of medical devices in Europe (24.01.2012)
Presentation on marketing of medical devices in Europe (24.01.2012)
 
Dr13 the future_of_health_care_insurance_whats_ahead3
Dr13 the future_of_health_care_insurance_whats_ahead3Dr13 the future_of_health_care_insurance_whats_ahead3
Dr13 the future_of_health_care_insurance_whats_ahead3
 
Omassmann presentation healthcare sector (1017)
Omassmann presentation healthcare sector (1017)Omassmann presentation healthcare sector (1017)
Omassmann presentation healthcare sector (1017)
 
Consumer prortection
Consumer prortectionConsumer prortection
Consumer prortection
 
Current Procedural Terminology
Current Procedural TerminologyCurrent Procedural Terminology
Current Procedural Terminology
 
Consumer protection
Consumer protectionConsumer protection
Consumer protection
 
Consumer protection act,1986 by Alpana
Consumer protection act,1986 by AlpanaConsumer protection act,1986 by Alpana
Consumer protection act,1986 by Alpana
 
Een mobiele gezondheidsapplicatie of wearables. Verhoog je kans op financiering.
Een mobiele gezondheidsapplicatie of wearables. Verhoog je kans op financiering.Een mobiele gezondheidsapplicatie of wearables. Verhoog je kans op financiering.
Een mobiele gezondheidsapplicatie of wearables. Verhoog je kans op financiering.
 
Vietnam – Healthcare and Medical Devices – Investment – With Outlook on the M...
Vietnam – Healthcare and Medical Devices – Investment – With Outlook on the M...Vietnam – Healthcare and Medical Devices – Investment – With Outlook on the M...
Vietnam – Healthcare and Medical Devices – Investment – With Outlook on the M...
 
consumer protection act.pptx
consumer protection act.pptxconsumer protection act.pptx
consumer protection act.pptx
 
Life Science and Healthcare Industry: Key Amendments in Budget 2022
Life Science and Healthcare Industry: Key Amendments in Budget 2022Life Science and Healthcare Industry: Key Amendments in Budget 2022
Life Science and Healthcare Industry: Key Amendments in Budget 2022
 

More from EY

EY Price Point: global oil and gas market outlook, Q2 | April 2022
EY Price Point: global oil and gas market outlook, Q2 | April 2022EY Price Point: global oil and gas market outlook, Q2 | April 2022
EY Price Point: global oil and gas market outlook, Q2 | April 2022
EY
 
EY Price Point: global oil and gas market outlook
EY Price Point: global oil and gas market outlookEY Price Point: global oil and gas market outlook
EY Price Point: global oil and gas market outlook
EY
 
EY Price Point: global oil and gas market outlook, Q2 April 2021
EY Price Point: global oil and gas market outlook, Q2 April 2021EY Price Point: global oil and gas market outlook, Q2 April 2021
EY Price Point: global oil and gas market outlook, Q2 April 2021
EY
 
EY Price Point: global oil and gas market outlook
EY Price Point: global oil and gas market outlookEY Price Point: global oil and gas market outlook
EY Price Point: global oil and gas market outlook
EY
 

More from EY (20)

EY Price Point Q3 2022
EY Price Point Q3 2022EY Price Point Q3 2022
EY Price Point Q3 2022
 
Quarterly analyst themes of oil and gas earnings, Q1 2022
Quarterly analyst themes of oil and gas earnings, Q1 2022Quarterly analyst themes of oil and gas earnings, Q1 2022
Quarterly analyst themes of oil and gas earnings, Q1 2022
 
EY Price Point: global oil and gas market outlook, Q2 | April 2022
EY Price Point: global oil and gas market outlook, Q2 | April 2022EY Price Point: global oil and gas market outlook, Q2 | April 2022
EY Price Point: global oil and gas market outlook, Q2 | April 2022
 
EY Price Point: global oil and gas market outlook
EY Price Point: global oil and gas market outlookEY Price Point: global oil and gas market outlook
EY Price Point: global oil and gas market outlook
 
EY Price Point: global oil and gas market outlook, Q2 April 2021
EY Price Point: global oil and gas market outlook, Q2 April 2021EY Price Point: global oil and gas market outlook, Q2 April 2021
EY Price Point: global oil and gas market outlook, Q2 April 2021
 
Tax Alerte - Principales dispositions loi de finances 2021
Tax Alerte - Principales dispositions loi de finances 2021Tax Alerte - Principales dispositions loi de finances 2021
Tax Alerte - Principales dispositions loi de finances 2021
 
EY Price Point: global oil and gas market outlook
EY Price Point: global oil and gas market outlookEY Price Point: global oil and gas market outlook
EY Price Point: global oil and gas market outlook
 
Tax Alerte - prix de transfert - PLF 2021
Tax Alerte - prix de transfert - PLF 2021Tax Alerte - prix de transfert - PLF 2021
Tax Alerte - prix de transfert - PLF 2021
 
EY Price Point: global oil and gas market outlook (Q4, October 2020)
EY Price Point: global oil and gas market outlook (Q4, October 2020)EY Price Point: global oil and gas market outlook (Q4, October 2020)
EY Price Point: global oil and gas market outlook (Q4, October 2020)
 
EY Price Point: global oil and gas market outlook
EY Price Point: global oil and gas market outlookEY Price Point: global oil and gas market outlook
EY Price Point: global oil and gas market outlook
 
Zahl der Gewinnwarnungen steigt auf Rekordniveau
Zahl der Gewinnwarnungen steigt auf RekordniveauZahl der Gewinnwarnungen steigt auf Rekordniveau
Zahl der Gewinnwarnungen steigt auf Rekordniveau
 
Versicherer rechnen mit weniger Neugeschäft
Versicherer rechnen mit weniger NeugeschäftVersicherer rechnen mit weniger Neugeschäft
Versicherer rechnen mit weniger Neugeschäft
 
Liquidity for advanced manufacturing and automotive sectors in the face of Co...
Liquidity for advanced manufacturing and automotive sectors in the face of Co...Liquidity for advanced manufacturing and automotive sectors in the face of Co...
Liquidity for advanced manufacturing and automotive sectors in the face of Co...
 
IBOR transition: Opportunities and challenges for the asset management industry
IBOR transition: Opportunities and challenges for the asset management industryIBOR transition: Opportunities and challenges for the asset management industry
IBOR transition: Opportunities and challenges for the asset management industry
 
Fusionen und Übernahmen dürften nach der Krise zunehmen
Fusionen und Übernahmen dürften nach der Krise zunehmenFusionen und Übernahmen dürften nach der Krise zunehmen
Fusionen und Übernahmen dürften nach der Krise zunehmen
 
Start-ups: Absturz nach dem Boom?
Start-ups: Absturz nach dem Boom?Start-ups: Absturz nach dem Boom?
Start-ups: Absturz nach dem Boom?
 
EY Price Point: global oil and gas market outlook, Q2, April 2020
EY Price Point: global oil and gas market outlook, Q2, April 2020EY Price Point: global oil and gas market outlook, Q2, April 2020
EY Price Point: global oil and gas market outlook, Q2, April 2020
 
Riding the crest of digital health in APAC
Riding the crest of digital health in APACRiding the crest of digital health in APAC
Riding the crest of digital health in APAC
 
EY Chemical Market Outlook - February 2020
EY Chemical Market Outlook - February 2020EY Chemical Market Outlook - February 2020
EY Chemical Market Outlook - February 2020
 
Jobmotor Mittelstand gerät ins Stocken
Jobmotor Mittelstand gerät ins Stocken Jobmotor Mittelstand gerät ins Stocken
Jobmotor Mittelstand gerät ins Stocken
 

Recently uploaded

abortion pills in Riyadh Saudi Arabia (+919707899604)cytotec pills in dammam
abortion pills in Riyadh Saudi Arabia (+919707899604)cytotec pills in dammamabortion pills in Riyadh Saudi Arabia (+919707899604)cytotec pills in dammam
abortion pills in Riyadh Saudi Arabia (+919707899604)cytotec pills in dammam
samsungultra782445
 
QATAR Pills for Abortion -+971*55*85*39*980-in Dubai. Abu Dhabi.
QATAR Pills for Abortion -+971*55*85*39*980-in Dubai. Abu Dhabi.QATAR Pills for Abortion -+971*55*85*39*980-in Dubai. Abu Dhabi.
QATAR Pills for Abortion -+971*55*85*39*980-in Dubai. Abu Dhabi.
hyt3577
 
FOREX FUNDAMENTALS: A BEGINNER'S GUIDE.pdf
FOREX FUNDAMENTALS: A BEGINNER'S GUIDE.pdfFOREX FUNDAMENTALS: A BEGINNER'S GUIDE.pdf
FOREX FUNDAMENTALS: A BEGINNER'S GUIDE.pdf
Cocity Enterprises
 
Abortion pills in Saudi Arabia (+919707899604)cytotec pills in dammam
Abortion pills in Saudi Arabia (+919707899604)cytotec pills in dammamAbortion pills in Saudi Arabia (+919707899604)cytotec pills in dammam
Abortion pills in Saudi Arabia (+919707899604)cytotec pills in dammam
samsungultra782445
 

Recently uploaded (20)

abortion pills in Riyadh Saudi Arabia (+919707899604)cytotec pills in dammam
abortion pills in Riyadh Saudi Arabia (+919707899604)cytotec pills in dammamabortion pills in Riyadh Saudi Arabia (+919707899604)cytotec pills in dammam
abortion pills in Riyadh Saudi Arabia (+919707899604)cytotec pills in dammam
 
Female Escorts Service in Hyderabad Starting with 5000/- for Savita Escorts S...
Female Escorts Service in Hyderabad Starting with 5000/- for Savita Escorts S...Female Escorts Service in Hyderabad Starting with 5000/- for Savita Escorts S...
Female Escorts Service in Hyderabad Starting with 5000/- for Savita Escorts S...
 
QATAR Pills for Abortion -+971*55*85*39*980-in Dubai. Abu Dhabi.
QATAR Pills for Abortion -+971*55*85*39*980-in Dubai. Abu Dhabi.QATAR Pills for Abortion -+971*55*85*39*980-in Dubai. Abu Dhabi.
QATAR Pills for Abortion -+971*55*85*39*980-in Dubai. Abu Dhabi.
 
Famous Kala Jadu, Black magic expert in Faisalabad and Kala ilam specialist i...
Famous Kala Jadu, Black magic expert in Faisalabad and Kala ilam specialist i...Famous Kala Jadu, Black magic expert in Faisalabad and Kala ilam specialist i...
Famous Kala Jadu, Black magic expert in Faisalabad and Kala ilam specialist i...
 
In Sharjah ௵(+971)558539980 *_௵abortion pills now available.
In Sharjah ௵(+971)558539980 *_௵abortion pills now available.In Sharjah ௵(+971)558539980 *_௵abortion pills now available.
In Sharjah ௵(+971)558539980 *_௵abortion pills now available.
 
W.D. Gann Theory Complete Information.pdf
W.D. Gann Theory Complete Information.pdfW.D. Gann Theory Complete Information.pdf
W.D. Gann Theory Complete Information.pdf
 
Test bank for advanced assessment interpreting findings and formulating diffe...
Test bank for advanced assessment interpreting findings and formulating diffe...Test bank for advanced assessment interpreting findings and formulating diffe...
Test bank for advanced assessment interpreting findings and formulating diffe...
 
Dubai Call Girls Deira O525547819 Dubai Call Girls Bur Dubai Multiple
Dubai Call Girls Deira O525547819 Dubai Call Girls Bur Dubai MultipleDubai Call Girls Deira O525547819 Dubai Call Girls Bur Dubai Multiple
Dubai Call Girls Deira O525547819 Dubai Call Girls Bur Dubai Multiple
 
FOREX FUNDAMENTALS: A BEGINNER'S GUIDE.pdf
FOREX FUNDAMENTALS: A BEGINNER'S GUIDE.pdfFOREX FUNDAMENTALS: A BEGINNER'S GUIDE.pdf
FOREX FUNDAMENTALS: A BEGINNER'S GUIDE.pdf
 
7 tips trading Deriv Accumulator Options
7 tips trading Deriv Accumulator Options7 tips trading Deriv Accumulator Options
7 tips trading Deriv Accumulator Options
 
fundamentals of corporate finance 11th canadian edition test bank.docx
fundamentals of corporate finance 11th canadian edition test bank.docxfundamentals of corporate finance 11th canadian edition test bank.docx
fundamentals of corporate finance 11th canadian edition test bank.docx
 
uk-no 1 kala ilam expert specialist in uk and qatar kala ilam expert speciali...
uk-no 1 kala ilam expert specialist in uk and qatar kala ilam expert speciali...uk-no 1 kala ilam expert specialist in uk and qatar kala ilam expert speciali...
uk-no 1 kala ilam expert specialist in uk and qatar kala ilam expert speciali...
 
Seeman_Fiintouch_LLP_Newsletter_May-2024.pdf
Seeman_Fiintouch_LLP_Newsletter_May-2024.pdfSeeman_Fiintouch_LLP_Newsletter_May-2024.pdf
Seeman_Fiintouch_LLP_Newsletter_May-2024.pdf
 
Group 8 - Goldman Sachs & 1MDB Case Studies
Group 8 - Goldman Sachs & 1MDB Case StudiesGroup 8 - Goldman Sachs & 1MDB Case Studies
Group 8 - Goldman Sachs & 1MDB Case Studies
 
Webinar on E-Invoicing for Fintech Belgium
Webinar on E-Invoicing for Fintech BelgiumWebinar on E-Invoicing for Fintech Belgium
Webinar on E-Invoicing for Fintech Belgium
 
20240419-SMC-submission-Annual-Superannuation-Performance-Test-–-design-optio...
20240419-SMC-submission-Annual-Superannuation-Performance-Test-–-design-optio...20240419-SMC-submission-Annual-Superannuation-Performance-Test-–-design-optio...
20240419-SMC-submission-Annual-Superannuation-Performance-Test-–-design-optio...
 
劳伦森大学毕业证
劳伦森大学毕业证劳伦森大学毕业证
劳伦森大学毕业证
 
Shrambal_Distributors_Newsletter_May-2024.pdf
Shrambal_Distributors_Newsletter_May-2024.pdfShrambal_Distributors_Newsletter_May-2024.pdf
Shrambal_Distributors_Newsletter_May-2024.pdf
 
Famous Kala Jadu, Kala ilam specialist in USA and Bangali Amil baba in Saudi ...
Famous Kala Jadu, Kala ilam specialist in USA and Bangali Amil baba in Saudi ...Famous Kala Jadu, Kala ilam specialist in USA and Bangali Amil baba in Saudi ...
Famous Kala Jadu, Kala ilam specialist in USA and Bangali Amil baba in Saudi ...
 
Abortion pills in Saudi Arabia (+919707899604)cytotec pills in dammam
Abortion pills in Saudi Arabia (+919707899604)cytotec pills in dammamAbortion pills in Saudi Arabia (+919707899604)cytotec pills in dammam
Abortion pills in Saudi Arabia (+919707899604)cytotec pills in dammam
 

The Medical Device Excise Tax: ready or not?

  • 1. 22nd Annual Health Sciences Tax Conference Medical device excise tax: ready or not? December 5, 2012
  • 2. Disclaimer ► Any US tax advice contained herein was not intended or written to be used, and cannot be used, for the purpose of avoiding penalties that may be imposed under the Internal Revenue Code or applicable state or local tax law provisions. Page 1 Medical device excise tax: ready or not?
  • 3. Disclaimer Ernst & Young refers to the global organization of member firms of Ernst & Young Global Limited, each of which is a separate legal entity. Ernst & Young LLP is a client- serving member firm of Ernst & Young Global Limited operating in the US. For more information about our organization, please visit www.ey.com. This presentation is © 2012 Ernst & Young LLP. All rights reserved. No part of this document may be reproduced, transmitted or otherwise distributed in any form or by any means, electronic or mechanical, including by photocopying, facsimile transmission, recording, rekeying, or using any information storage and retrieval system, without written permission from Ernst & Young LLP. Any reproduction, transmission or distribution of this form or any of the material herein is prohibited and is in violation of US and international law. Ernst & Young LLP expressly disclaims any liability in connection with use of this presentation or its contents by any third party. Views expressed in this presentation are not necessarily those of Ernst & Young LLP. Page 2 Medical device excise tax: ready or not?
  • 4. Presenters ► Mar Haeussler ► Chris Ohmes Vice President Ernst & Young LLP Economic Analysis/Transfer Washington, DC Pricing +1 202 327 8753 Olympus Center Valley, PA chris.ohmes@ey.com Page 3 Medical device excise tax: ready or not?
  • 5. Agenda ► Introduction to MDET ► Preparation for the medical device excise tax (MDET) ► Supply chain mapping ► Tax base ► When liability arises ► Amount of Liability ► Compliance and IT considerations Page 4 Medical device excise tax: ready or not?
  • 7. What is the MDET? ► The MDET is a federal, ad valorem, manufacturers excise tax. ► Enacted as part of the Patient Protection and Affordable Care Act, the MDET imposes on manufacturers, importers, and producers a tax at a rate of 2.3% of the price of the first sale or use of medical devices in the US. ► The MDET is effective for taxable sales (and uses) occurring after December 31, 2012. ► The MDET is incorporated into Chapter 32 of the Internal Revenue Code, thus a series of existing manufacturers excise tax rules apply to the MDET. Page 6 Medical device excise tax: ready or not?
  • 9. Where to start? ► Do we obtain ownership of taxable medical devices in a way that potentially make us liable for the tax? ► Do we make them? ► Did we import them? ► Are we treated as if we made them? ► What about: ► Kitting ► Installation and/or periodic servicing ► Repairs/refurbishing Page 8 Medical device excise tax: ready or not?
  • 10. What are we talking about? ► Taxable medical devices are defined with reference to Section 201(h) of the Federal Food, Drug and Cosmetic Act. A medical device is: ► An instrument, apparatus, contrivance, in vitro reagent, recognized in the National Formulary or the US Pharmacopoeia ► Intended for use in diagnosis of disease or other conditions or in the cure, mitigation, treatment or prevention of disease ► Intended to affect the structure or any function of the body of man or other animals, in a non-chemical manner Page 9 Medical device excise tax: ready or not?
  • 11. Who is liable for the tax? ► MDET is imposed on the manufacturer, producer or importer of a taxable medical device. ► For excise tax purposes, the term manufacturer includes a “producer” and an “importer.” ► A manufacturer is a person who produces a taxable article by processing, manipulating or changing the form of an article or, by combining or assembling two or more articles. ► The importer rule treats the importer as the manufacturer of imported goods. ► MDET applies by legal entity, thus multiple entities within a controlled group can have compliance obligations. Page 10 Medical device excise tax: ready or not?
  • 12. Which devices are exempt? ► Exemptions based on the product ► Some medical devices are MDET-exempt because they are not listed with a three-letter Food and Drug Administration (FDA) product code. ► Eyeglasses, hearing aids and contact lenses ► Certain medical devices sold at retail, as specified in regulations ► Exemptions based on sales ► Exports (can we prove it?) ► Sold for further manufacturing (shifting of liability) Page 11 Medical device excise tax: ready or not?
  • 13. The retail exemption isn’t sales based? ► Congress delegated to Treasury the authority to exempt medical devices, which are of a type generally purchased by the general public at retail for individual. ► Internal Revenue Service (IRS) has proposed regulations indicating the retail exemption applies to medical devices ► The device satisfies a three-part test: ► It is regularly available for purchase and use by individual consumers who are not medical professionals. ► The design demonstrates that it is not primarily intended for use in in a medical institution or office or by medical professionals. ► Alternatively, the device satisfies one of the regulations’ safe harbor provisions Page 12 Medical device excise tax: ready or not?
  • 14. Triggering liability for the tax ► In general, the tax attaches to the first sale in the US after the completion of manufacturing of a taxable medical device ► Importers are subject to the same first sale rule, when a taxable medical device is imported into the US. ► Uses are also subject to the MDET ► Leases ► Rental arrangements not involving payments of rent ► Loaners ► Demonstration units Page 13 Medical device excise tax: ready or not?
  • 15. Section 4191 medical device excise tax point of attachment Do you manufacture, produce, or import Yes Do you export Yes listed FDA medical No tax medical devices? devices for use by humans? No No Do you sell partially completed Yes No tax medical devices? No tax No Are they eyeglasses, contact lenses, Yes No tax hearing aids or exempt devices? Yes No Do you sell, rent, lease, lend or use Yes Tax due medical devices? Page 14 Medical device excise tax: ready or not?
  • 17. Identifying the tax price ► The supply chain and distribution channels determine which prices can be used to calculate the tax. ► Existing manufacturers’ excise tax rules assume a certain supply chain and distribution-channel paradigm – pricing rules follow from that paradigm. ► Supply chain and distribution channels vary widely in the medical device industry. ► Economic versus legal responsibility for MDET Page 16 Medical device excise tax: ready or not?
  • 18. The pricing paradigm Seeking a manufacturer’s wholesale price US Unrelated Unrelated End manufacturer or distributer retailer customer Importer Page 17 Medical device excise tax: ready or not?
  • 19. What is a constructive sales price? ► A fair market value price that the IRS may impose by statute ► Applies only if tax is not paid on fair market value price. ► IRS has issued numerous rulings allowing a fixed percentage of retail as a proxy for a wholesale price but these are specific to other excise taxes. ► Most MDET taxpayers will want to avoid constructive pricing ► Constructive price rules are set out in code Section 4216(b)(1) through (b)(4) Page 18 Medical device excise tax: ready or not?
  • 20. At what price is the tax paid? Constructive price rules Taxable Transaction is always the first sale or use Constructive Sales Price Taxable Sale Unrelated Transfer Price wholesaler/ True wholesale distributer E n d Related US wholesaler/ manufacturer distributer c Outside US or u (OUS) importer Unrelated s manufacturer retailer t o Related m retailer e r Page 19 Medical device excise tax: ready or not?
  • 21. Determining pricing ► Price must reflect a return for all functions, intangibles and risks necessary to manufacture a finished device ready for the market ► Existing regulations provide for the following exclusions ► Excise tax ► Transportation ► Delivery ► Insurance ► Installation charges Page 20 Medical device excise tax: ready or not?
  • 22. Pricing hot topics ► Separately stating the tax on invoices ► Intercompany sales to related distribution company ► Rebates and sales incentives ► Treatment of marketing intangibles and marketing costs ► Services incorporated into sales price (training, repairs, loaners, etc.) ► Application of Rev Rul 80-273 ► Vendor communications on tax-exempt sales ► Razor and razor blade sales model Page 21 Medical device excise tax: ready or not?
  • 24. Compliance issues ► Tax deposits every two weeks, electronic federal tax payment system per legal entity ► Quarterly form 720 (yet to be modified for MDET) ► Form 637 exemption certificates ► Acquire ► Provide ► Maintain ► Record retention (and compliance with export and further manufacturing regulations) ► Refunds Page 23 Medical device excise tax: ready or not?
  • 25. Compliance issues ► No off the shelf software solution is available ► Integration with Enterprise Resource Planning Software (ERP) or standalone? ► Systems ► Calculate tax and refunds ► Create audit reports ► Update financials ► Customer relationship changes ► Supplier relationship changes ► Item master changes ► Acquisitions Page 24 Medical device excise tax: ready or not?
  • 26. Questions Page 25 Medical device excise tax: ready or not?